Connect with Healthcetera
Wednesday, April 24, 2024
HomeStandard Blog Whole Post (Page 3)

Photo by Mehdi Imani on Unsplash

Jacqueline Saltarelli is the Assistant Director for New York City Treats Tobacco.  She leads a health systems approach to reduce tobacco-related disparities, morbidity, and mortality by managing partnerships with organization leaders to develop and implement tobacco-dependence treatment policies and procedures that align with evidence-based best practices. She also trains providers on tobacco dependence treatment best practices, health inequities that exist within their communities, emerging issues, and sustainable policy solutions.

Photo by Mehdi Imani on Unsplash Jacqueline Saltarelli is

Dr. Junxin Li is an Associate Professor at John Hopkins University School of Nursing. She is a nurse scientist who focuses on the health and well-being of older adults and how physical activity and sleep affect cognitive function. She addresses the myth that not all elderly people sleep worse as they age and why sleep is critical to your health. 

Dr. Junxin Li is an Associate Professor

Photo by National Cancer Institute on Unsplash

Last Friday the FDA approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

Dr. Dora Clayton- Jones is an Associate Professor, at Marquette University College of Nursing, a Board Member of the, International Association of Sickle Cell Nurses and Professional Associates, and a U C Davis Fellow, Betty Irene Moore Fellowships for Nurse Leaders and Innovators  One of her areas of expertise is focusing on transitions of care for adolescents living with sickle cell disease. She is committed to eliminating sickle cell disparities among youth.

Photo by National Cancer Institute on Unsplash Last